نتائج البحث

المساهمون: Brugts, Jj, Isaacs, A, de Maat, Mp, Boersma, E, van Duijn, Cm, Akkerhuis, Km, Uitterlinden, Ag, Witteman, Jc, Cambien, F, Ceconi, Claudio, Remme, W, Bertrand, M, Ninomiya, T, Harrap, S, Chalmers, J, Macmahon, S, Fox, K, Ferrari, Roberto, Simoons, Ml, Danser, A. J.

مصطلحات موضوعية: ACE inhibitor, gene, hypertension, PERGENE, pharmacogenetic, polymorphism, PROGRESS, renin-angiotensin-aldosterone system

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000287236600017; volume:29; issue:3; firstpage:509; lastpage:519; journal:JOURNAL OF HYPERTENSION; http://hdl.handle.net/11392/1735104Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-79951673075

الإتاحة: https://doi.org/10.1097/HJH.0b013e328341d117Test
http://hdl.handle.net/11392/1735104Test

View record in BASE

4

دورية أكاديمية

Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease

المؤلفون: Brugts, J.J. (Jasper), Isaacs, A.J. (Aaron), Boersma, H. (Eric), Duijn, C.M. (Cornelia) van, Uitterlinden, A.G. (André), Remme, W.J. (Willem), Bertrand, M.E. (Michel), Ninomiya, T. (T.), Ceconi, C. (Claudio), Chalmers, J. (John), MacmMahon, S. (Stephen), Fox, K.M. (Kim), Ferrari, R. (Roberto), Witteman, J.C.M. (Jacqueline), Danser, A.H.J. (Jan), Simoons, M.L. (Maarten), Maat, M.P.M. (Moniek) de

المصدر: European Heart Journal vol. 31 no. 15, pp. 1854-1864

مصطلحات موضوعية: ACE-inhibitors, Coronary artery disease, Gene, Individualized-therapy, PERGENE, Perindopril, Pharmacogenetics, RAAS

العلاقة: https://repub.eur.nl/pub/21072Test; urn:hdl:1765/21072

الإتاحة: https://doi.org/10.1093/eurheartj/ehq169Test
https://repub.eur.nl/pub/21072Test

View record in BASE

5

دورية أكاديمية

The rationale and design of the perindopril genetic association study (PERGENE): A pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease

المؤلفون: Brugts, J.J. (Jasper), Maat, M.P.M. (Moniek) de, Boersma, H. (Eric), Witteman, J.C.M. (Jacqueline), Duijn, C.M. (Cornelia) van, Uitterlinden, A.G. (André), Bertrand, M.E. (Michel), Remme, W.J. (Willem), Fox, K.M. (Kim), Ferrari, R. (Roberto), Danser, A.H.J. (Jan), Simoons, M.L. (Maarten)

المصدر: Cardiovascular Drugs and Therapy vol. 23 no. 2, pp. 171-181

مصطلحات موضوعية: ACE-inhibitor, Coronary artery disease, Gene, Haplotypes, PERGENE, Perindopril, Pharmacogenetics, Polymorphism

وصف الملف: application/pdf

العلاقة: https://repub.eur.nl/pub/24212Test; urn:hdl:1765/24212

الإتاحة: https://doi.org/10.1007/s10557-008-6156-1Test
https://repub.eur.nl/pub/24212Test

View record in BASE

6

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals

المساهمون: Cardiology, Epidemiology, Hematology, Internal Medicine

المصدر: Journal of Hypertension, 29(3), 509-19. LIPPINCOTT WILLIAMS & WILKINS
Journal of Hypertension, 29(3), 509-519. Lippincott Williams & Wilkins

مصطلحات موضوعية: Receptors, Cell Surface/genetics, Male, ACE inhibitors, Physiology, Angiotensinogen, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Gastroenterology, Plasma renin activity, polymorphism, chemistry.chemical_compound, Receptors, Perindopril, Prorenin Receptor, pharmacogenetics, Hypertension/drug therapy, gene, hypertension, PERGENE, PROGRESS, renin-angiotensin-aldosterone system, Single Nucleotide, Middle Aged, Female, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, Receptors, Cell Surface, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Peptidyl-Dipeptidase A/genetics, Peptidyl-Dipeptidase A, Polymorphism, Single Nucleotide, Blood Pressure/drug effects, Internal medicine, Internal Medicine, medicine, Humans, Aged, Cell Surface/genetics, business.industry, Vascular disease, Aliskiren, medicine.disease, Blood pressure, Endocrinology, chemistry, Haplotypes, ACE inhibitor, Gene polymorphism, Angiotensinogen/genetics, business, Pharmacogenetics